DSG1 and acquired polycythemia vera: A significant decrease in disease activity from T1 to T2, as evidenced by a decrease in PDAI score as well as a decrease in anti-DSG1 and -DSG3 Ab titers, was seen in both PF and PV patients and was seen in both treatment groups (Fig 1E and 1F, Table 2, S1 Table).